The United Kingdom Autoimmune Disease Therapeutics Market
The United Kingdom Autoimmune Disease Therapeutics Market size is forecast to grow from approximately USD 93.5 Billion in 2025 to around USD 184.2Billion by 2035. According to Decision Advisors, a detailed research report on the autoimmune disease therapeutics market indicates that the rapid adoption of biologics trend dominates the market, accounting for approximately 35-40% of the total share in the United Kingdom. AbbVie Inc. leads the market with an estimated 21% United Kingdom market share. The company\'s annual revenue of approximately USD 54-56 billion is making it one of the most influential forces shaping industry trends and overall market growth.